{
    "eid": "2-s2.0-85138458285",
    "title": "Expression of Programmed Cell Death-1 and Programmed Cell Death Ligands in Nodal Peripheral T-Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance",
    "cover-date": "2022-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Immune checkpoint",
        "Peripheral T-cell lymphoma",
        "Prognosis",
        "Programmed cell death"
    ],
    "authors": [
        "Thiti Asawapanumas",
        "Nichthida Tangnantachai",
        "Narittee Sukswai",
        "Thammathorn Assanasen",
        "Chantiya Chanswangphuwana",
        "Panisinee Lawsut",
        "Chantana Polprasert",
        "Ponlapat Rojnuckarin",
        "Udomsak Bunworasate",
        "Kitsada Wudhikarn"
    ],
    "citedby-count": 0,
    "ref-count": 19,
    "ref-list": [
        "Coinhibitory pathways in immunotherapy for cancer",
        "Functional expression of programmed death-ligand 1 (B7-H1) by immune cells and tumor cells",
        "PD-1/PD-L1 immune checkpoint: potential target for cancer therapy",
        "Checkpoint blockade in hodgkin and non-hodgkin lymphoma",
        "Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders",
        "CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: possible biomarkers for novel targeted therapies?",
        "A novel subset of T-helper cells: follicular T-helper cells and their markers",
        "Application of a 5 marker panel to the routine diagnosis of peripheral T-cell lymphoma with T-follicular helper phenotype",
        "Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes",
        "Mechanisms of PD-1/PD-L1 expression and prognostic relevance in non-hodgkin lymphoma: A summary of immunohistochemical studies",
        "PD-L1 and PD1 expression in lymphomas",
        "Comparison of different antibody clones for immunohistochemistry detection of programmed cell death ligand 1 (PD-L1) on non-small cell lung carcinoma",
        "The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: A meta-analysis",
        "High PD-L1 expression predicts poor prognosis in diffuse large B-cell lymphoma",
        "Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas",
        "Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type",
        "PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult Tcell leukemia/lymphoma",
        "Expression of PD-1 and PD-L1 on cytotoxic T lymphocytes and immune deficiency in a patient with adult T cell leukemia/lymphoma",
        "Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Cancer Run Research Foundation Thailand",
        "Royal College of Physician Thailand"
    ]
}